Health
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
We conducted a global, randomized, placebo-controlled, phase 123 pivotal trial in which two 30-g doses of BNT162b2 (PfizerBioNTech) were administered 21 days apart (ClinicalTrials.gov number, NCT04368728). These doses of vaccine had mainly low-grade side…
Continue Reading
-
Noosa News23 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Noosa News21 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business14 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News14 hours agoInside the Brisbane suburb that homeowners refuse to leave